Evidence map›Paper›PMID 24348687›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2013

Electroacupuncture-Induced Neuroprotection against Cerebral Ischemia in Rats: Role of the Dopamine D2 Receptor.

Ming-Shu Xu, Shu-Jing Zhang, Dan Zhao, Cheng-Yong Liu, Chang-Zhi Li, Chun-Yan Chen, Li-Hui Li, Ming-Zhe Li, Jia Xu, Lin-Bao Ge

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Mechanisms of Acupuncture Therapy for Cerebral Ischemia: an Evidence-Based Review of Clinical and Animal Studies on Cerebral Ischemia.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2017
    Review
  6. Effects of "nourishing liver and kidney" acupuncture therapy on expression of brain derived neurotrophic factor and synaptophysin after cerebral ischemia reperfusion in rats.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ming-Shu XuNeurobiology Laboratory of Brain, Shanghai Research Institute of Acupuncture and Meridians, Shanghai 200030, China.
Shu-Jing ZhangNeurobiology Laboratory of Brain, Shanghai Research Institute of Acupuncture and Meridians, Shanghai 200030, China.
Dan ZhaoShanghai Research Institute of Qigong, Shanghai 200030, China.
Cheng-Yong LiuJiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, China.
Chang-Zhi LiYueyang Hospital of Integrative Chinese & Western Medicine Affiliated to Shanghai University of TCM, Shanghai 200437, China.
Chun-Yan ChenShanghai Research Institute of Qigong, Shanghai 200030, China.
Li-Hui LiNeurobiology Laboratory of Brain, Shanghai Research Institute of Acupuncture and Meridians, Shanghai 200030, China.
Ming-Zhe LiNeurobiology Laboratory of Brain, Shanghai Research Institute of Acupuncture and Meridians, Shanghai 200030, China.
Jia XuYueyang Hospital of Integrative Chinese & Western Medicine Affiliated to Shanghai University of TCM, Shanghai 200437, China.
Lin-Bao GeShanghai Research Institute of Qigong, Shanghai 200030, China ; Shanghai Research Center of Acupuncture and Meridians, Shanghai 201203, China.
Shanghai Research Center for Acupuncture and Meridians · CNShanghai University of Traditional Chinese Medicine · CNJiangsu Provincial Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Cerebral ischemia is known to produce brain damage and related behavioural deficits, including memory deficits and motor disorders. Evidence shows that EA significantly promotes recovery of neurological function and thus improves quality of life. Objective. Evidence exists for the involvement of catecholamines in human neuroplasticity. A better understanding of dopaminergic (DAergic) modulation in this process will be important. Methods. A total of 72 adult male Sprague-Dawley (SD) rats were divided into 6 groups: normal, model, EA, spiperone group, EA + spiperone group, and pergolide. The middle cerebral artery occlusion (MCAO) model was used in all 6 groups except the normal group. A behavioural assessment was conducted at 1, 3, 5, and 7 days after MCAO. The percent of brain infarct area was also determined 7 days after MCAO. Tyrosine hydroxylase (TH) and growth-associated protein 43 (GAP-43) fluorescence double labeling was performed in the striatum. Results. In this study, we found that EA at Fengchi (GB20) acupoints resulted in marked improvements based on a behavioural assessment. Both TTC staining and GAP-43 immunofluorescence labeling results showed that EA treatment reduced ischemia injury and promoted neuroplasticity compared with the model group. The D2R-selective agonist, pergolide, showed similar results, but these results were reversed by the D2R-selective antagonist, spiperone. We also found that there were more colocalization and expression of GAP-43 and TH in the EA and pergolide groups than those in the other groups. Conclusion. These results suggest that the neuroplasticity induced by EA was mediated by D2 autoreceptors in DAergic neurons.

Identifiers

PMID24348687
PMCPMC3856151
OpenAlexW2169362891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.